 SAN DIEGO, Oct. 24, 2022 GLOBE NEWSWIRE -- Singular Genomics Systems, Inc. Nasdaq: OMIC, a company leveraging novel next-generation sequencing NGS and multiomics technologies to empower researchers and clinicians, today announced that it will report financial results for the third quarter 2022 after the market close on Monday, November 7, 2022. The companys management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time 4:30 p.m. Eastern Time. 